Loading…
Loading…
Abstract P2-14-03: A pilot study of paclitaxel plus pembrolizumab in patients with metastatic HER2-negative breast cancer (PePPy)
Tan, Antoinette R., Chai, S. Jean, Robinson, Myra M., Hellner, Lane B., Gavini, Nagajyothi, Sulai, Nanna, Turner, J. David, Atlas, Jennifer, Graham, David L., Induru, Raghava R., Kadakia, Kunal C., Vallabhaneni, Geetha D., Heeke, Arielle L., Foureau, David M., Fisher, Julie G.
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Loading…
A pilot study evaluating the safety, tolerability, and efficacy of doxorubicin and pembrolizumab in patients with metastatic or unresectable soft tissue sarcoma
Livingston, Michael B., Jagosky, Megan, Robinson, Myra M., Ahrens, William, Benbow, Jennifer H, Farhangfar, Carol J., Foureau, David, Maxwell, Deirdre, Baldrige, Emily, Steuerwald, Nury, Anderson, Colin J, Patt, Joshua, Kneisl, Jeffrey, Kim, Edward S.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Loading…
Pilot study of dovitinib in patients with VHL disease
Pilie, Patrick Glen, Matin, Surena F., Woodson, Ashley Henriksen, Marcott, Valerie D., Bird, Shelly, Slack, Rebecca, Fuller, Greg, McCutcheon, Ian E., Jonasch, Eric
Published in Journal of clinical oncology (10.01.2016)
Published in Journal of clinical oncology (10.01.2016)
Get full text
Journal Article